BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16450750)

  • 1. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis.
    Rashid G; Korzets Z; Bernheim J
    Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
    Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
    J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis.
    Matsuo K; Ikizler TA; Hoover RL; Nakamoto M; Yasunaga C; Pupim LB; Hakim RM
    Kidney Int; 2000 Feb; 57(2):697-708. PubMed ID: 10652049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
    Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
    J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function.
    Jones S; Holmes CJ; Mackenzie RK; Stead R; Coles GA; Williams JD; Faict D; Topley N
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S97-103. PubMed ID: 11792769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis.
    Iida Y; Miyata T; Inagi R; Sugiyama S; Maeda K
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1235-41. PubMed ID: 8024566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin enhances monocyte secretion of tumor necrosis factor and interleukin-1 beta by two distinct mechanisms.
    Hoffman M; Cooper ST
    Blood Cells Mol Dis; 1995; 21(2):156-67. PubMed ID: 8846045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
    Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D
    Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.
    Miyata T; Hori O; Zhang J; Yan SD; Ferran L; Iida Y; Schmidt AM
    J Clin Invest; 1996 Sep; 98(5):1088-94. PubMed ID: 8787669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages.
    Cavaillon JM; Fitting C; Haeffner-Cavaillon N
    Eur J Immunol; 1990 Feb; 20(2):253-7. PubMed ID: 1690130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages.
    Persson J; Nilsson J; Lindholm MW
    Lipids Health Dis; 2006 Jun; 5():17. PubMed ID: 16800873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of IL-1 beta and TNF-alpha by peritoneal macrophages depends on the bacterial species and the inoculum.
    Visser CE; Brouwer-Steenbergen JJ; Struijk G; Krediet RT; Beelen RH
    Adv Perit Dial; 1997; 13():201-4. PubMed ID: 9360681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
    J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P
    J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis.
    Hou FF; Miyata T; Boyce J; Yuan Q; Chertow GM; Kay J; Schmidt AM; Owen WF
    Kidney Int; 2001 Mar; 59(3):990-1002. PubMed ID: 11231354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients.
    Nakamura S; Tachikawa T; Tobita K; Miyazaki S; Sakai S; Morita T; Hirasawa Y; Weigle B; Pischetsrieder M; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S61-7. PubMed ID: 12612955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of monocyte/macrophage cytokine production by pressure.
    Shiratsuch H; Basson MD
    Am J Surg; 2005 Nov; 190(5):757-62. PubMed ID: 16226954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.